VTYX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 49.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $36,781,042.82

Ventyx Biosciences Insider Trading History Chart

Ventyx Biosciences Share Price & Price History

^$42.56

▼ -1.39 (-3.16%)

As of 02/7/2023 05:08 PM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

Click here now!

Ventyx Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/23/2023	William Richard White	Director	Sell	33,353	$35.10	$1,170,690.30
12/22/2022	John Nuss	Insider	Sell	13,812	$31.61	$436,597.32	244,815
12/22/2022	Raju Mohan	CEO	Sell	55,354	$31.61	$1,749,739.94	1,603,126
12/16/2022	Somu Subramaniam	Director	Sell	146,825	$32.94	$4,836,415.50	12,974,786
12/15/2022	Nsv Partners Iii Lp	Major Shareholder	Sell	153,175	$33.61	$5,148,211.75	13,121,611
12/13/2022	Christopher W Krueger	Insider	Sell	30,000	$34.46	$1,033,800.00	272,692
12/5/2022	John Nuss	Insider	Sell	50,000	$28.23	$1,411,500.00	258,696
12/5/2022	Raju Mohan	CEO	Sell	23,003	$28.44	$654,205.32	1,541,811
12/2/2022	Christopher W Krueger	Insider	Sell	50,000	$29.01	$1,450,500.00	302,692
12/2/2022	Martin Auster	CFO	Sell	97,647	$29.01	$2,832,739.47	47,649
12/2/2022	Raju Mohan	CEO	Sell	276,997	$29.01	$8,035,682.97	1,564,814
12/1/2022	Somu Subramaniam	Director	Sell	129,317	$29.01	$3,751,486.17	16,616,048
11/30/2022	Nsv Partners Iii Lp	Major Shareholder	Sell	143,228	$29.01	$4,155,044.28	16,745,365
11/7/2022	Somu Subramaniam	Director	Sell	3,935	$29.08	$114,429.80	16,888,593
10/25/2021	Global Strategic Fund I Venbio	Major Shareholder	Buy	312,500	$16.00	$5,000,000.00

GRAPHITE: "Essential for America's National Defense"

From Investing Trends | Ad

Did you know each EV battery contains up to 220 pounds of graphite and China controls more than 90% of the world's graphite trade? But now that the U.S. has classified it as "essential for America's National Defense"... one little-known company could become America's ONLY fully integrated graphite provider.

Discover Who's Poised to Benefit

SEC Filings (Institutional Ownership Changes) for Ventyx Biosciences (NASDAQ:VTYX)

95.57% of Ventyx Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Ventyx Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/7/2023	TD Asset Management Inc	30,836	$1.01M	0.0%	+89.9%	0.054%
2/3/2023	Birchview Capital LP	22,000	$0.72M	0.5%	-51.1%	0.039%
2/2/2023	SG Americas Securities LLC	7,975	$0.26M	0.0%	+110.8%	0.014%
2/2/2023	ProShare Advisors LLC	7,893	$0.26M	0.0%	N/A	0.014%
2/1/2023	Zurcher Kantonalbank Zurich Cantonalbank	2,032	$67K	0.0%	N/A	0.004%
2/1/2023	Janney Montgomery Scott LLC	12,957	$0.43M	0.0%	-38.0%	0.023%
1/30/2023	New York State Common Retirement Fund	15,465	$0.51M	0.0%	-21.7%	0.027%
1/25/2023	Connective Portfolio Management LLC	15,000	$0.49M	1.0%	N/A	0.026%
1/24/2023	Moody Aldrich Partners LLC	79,250	$2.60M	0.5%	N/A	0.140%
1/24/2023	Carnegie Capital Asset Management LLC	15,708	$0.52M	0.0%	N/A	0.028%
1/20/2023	Avestar Capital LLC	6,469	$0.21M	0.0%	N/A	0.011%
12/8/2022	Bank of New York Mellon Corp	80,445	$2.81M	0.0%	+60.0%	0.142%
11/28/2022	Birchview Capital LP	45,000	$1.57M	1.1%	+36.4%	0.079%
11/21/2022	California State Teachers Retirement System	8,852	$0.31M	0.0%	-7.6%	0.016%
11/16/2022	Advisory Research Inc.	31,726	$1.11M	0.1%	N/A	0.056%
11/16/2022	Fred Alger Management LLC	11,879	$0.42M	0.0%	N/A	0.021%
11/16/2022	Maven Securities LTD	150,000	$5.24M	0.1%	N/A	0.265%
11/15/2022	Alliancebernstein L.P.	15,200	$0.53M	0.0%	N/A	0.027%
11/15/2022	State Street Corp	440,943	$15.39M	0.0%	+35.5%	0.779%
11/15/2022	Two Sigma Advisers LP	8,000	$0.28M	0.0%	N/A	0.014%
11/15/2022	Two Sigma Investments LP	91,395	$3.19M	0.0%	N/A	0.161%
11/15/2022	Tri Locum Partners LP	125,000	$4.36M	1.2%	N/A	0.221%
11/15/2022	Vanguard Group Inc.	1,103,953	$38.54M	0.0%	+21.7%	1.949%
11/15/2022	Price T Rowe Associates Inc. MD	685,342	$23.93M	0.0%	N/A	1.210%
11/15/2022	Lord Abbett & CO. LLC	1,737,778	$60.67M	0.2%	N/A	3.068%
11/15/2022	Logos Global Management LP	1,397,680	$48.79M	6.0%	-39.6%	2.468%
11/15/2022	EcoR1 Capital LLC	400,000	$13.96M	0.4%	-69.2%	0.706%
11/15/2022	Farallon Capital Management LLC	70,000	$2.44M	0.0%	-92.5%	0.124%
11/15/2022	Bank of New York Mellon Corp	80,445	$2.81M	0.0%	+60.0%	0.142%
11/15/2022	BlackRock Inc.	1,381,503	$48.23M	0.0%	+30.7%	2.439%
11/15/2022	Boxer Capital LLC	850,000	$29.67M	1.7%	N/A	1.501%
11/15/2022	Caas Capital Management LP	60,000	$2.03M	0.1%	N/A	0.106%
11/14/2022	Royal Bank of Canada	5,622	$0.20M	0.0%	+4,326.8%	0.010%
11/14/2022	Tudor Investment Corp Et Al	22,400	$0.78M	0.0%	-37.1%	0.040%
11/14/2022	Vivo Capital LLC	1,355,861	$47.33M	5.2%	-29.4%	2.394%
11/14/2022	Cubist Systematic Strategies LLC	24,089	$0.84M	0.0%	N/A	0.043%
11/14/2022	Darwin Global Management Ltd.	1,401,123	$48.91M	73.7%	N/A	2.474%
11/14/2022	Renaissance Technologies LLC	5,800	$0.20M	0.0%	N/A	0.010%
11/14/2022	Nuveen Asset Management LLC	69,051	$2.41M	0.0%	-0.6%	0.122%
11/14/2022	VR Adviser LLC	207,925	$7.26M	1.1%	N/A	0.367%
11/14/2022	Integral Health Asset Management LLC	100,000	$3.49M	0.7%	N/A	0.177%
11/14/2022	UBS Oconnor LLC	29,400	$1.03M	0.0%	N/A	0.052%
11/14/2022	Pictet Asset Management SA	1,071,983	$37.42M	0.1%	N/A	1.893%
11/14/2022	Maven Securities LTD	150,000	$5.24M	0.1%	N/A	0.265%
11/10/2022	Nantahala Capital Management LLC	116,633	$4.07M	0.3%	N/A	0.206%
11/10/2022	ExodusPoint Capital Management LP	11,867	$0.41M	0.0%	N/A	0.021%
11/8/2022	Qiming U.S. Ventures Management LLC	746,370	$26.06M	37.8%	-18.0%	1.320%
11/8/2022	New York State Common Retirement Fund	19,752	$0.69M	0.0%	+61.3%	0.035%
11/8/2022	Moors & Cabot Inc.	6,000	$0.21M	0.0%	N/A	0.011%
11/7/2022	Birchview Capital LP	45,000	$1.57M	1.1%	+36.4%	0.080%
11/7/2022	TD Asset Management Inc.	16,240	$0.57M	0.0%	N/A	0.029%
11/3/2022	The Manufacturers Life Insurance Company	27,960	$0.98M	0.0%	N/A	0.049%
11/3/2022	Barclays PLC	3,048	$0.11M	0.0%	-98.9%	0.005%
11/2/2022	DekaBank Deutsche Girozentrale	15,000	$0.53M	0.0%	N/A	0.027%
10/31/2022	SG Americas Securities LLC	3,783	$0.13M	0.0%	N/A	0.007%
10/25/2022	Janney Montgomery Scott LLC	20,884	$0.73M	0.0%	+10.3%	0.037%
10/24/2022	High Net Worth Advisory Group LLC	1,000	$35K	0.0%	+100.0%	0.002%
8/22/2022	Legal & General Group Plc	2,422	$30K	0.0%	+152.3%	0.005%
8/18/2022	Goldman Sachs Group Inc.	18,868	$0.23M	0.0%	N/A	0.037%
8/16/2022	Driehaus Capital Management LLC	635,992	$7.78M	0.1%	-0.7%	1.251%
8/15/2022	State Street Corp	325,336	$3.98M	0.0%	+90.0%	0.640%
8/15/2022	Acuta Capital Partners LLC	122,000	$1.49M	0.8%	+72.1%	0.240%
8/15/2022	Point72 Asset Management L.P.	206,400	$2.52M	0.0%	-8.8%	0.406%
8/15/2022	Citadel Advisors LLC	3,891,328	$47.59M	0.0%	-0.5%	7.653%
8/13/2022	Tokio Marine Asset Management Co. Ltd.	10,800	$0.13M	0.0%	N/A	0.021%
8/13/2022	American International Group Inc.	10,490	$0.13M	0.0%	+102.3%	0.021%
8/12/2022	Northern Trust Corp	166,643	$2.04M	0.0%	+93.2%	0.328%
8/12/2022	Virtus ETF Advisers LLC	7,970	$97K	0.0%	N/A	0.016%
8/12/2022	FMR LLC	1,575,942	$19.27M	0.0%	+92.9%	3.099%
8/12/2022	Rhumbline Advisers	25,437	$0.31M	0.0%	N/A	0.050%
8/11/2022	UBS Group AG	2,052	$25K	0.0%	-28.5%	0.004%
8/11/2022	JPMorgan Chase & Co.	11,984	$0.15M	0.0%	+57.8%	0.024%
8/3/2022	Janney Montgomery Scott LLC	18,934	$0.23M	0.0%	N/A	0.037%
6/7/2022	Bank of America Corp DE	30,680	$0.42M	0.0%	-34.6%	0.060%
5/17/2022	Great Point Partners LLC	336,334	$4.56M	1.1%	N/A	0.661%
5/16/2022	California State Teachers Retirement System	4,428	$60K	0.0%	-22.7%	0.009%
5/16/2022	Matrix Capital Management Company LP	335,000	$4.55M	0.1%	N/A	0.658%
5/16/2022	Wellington Management Group LLP	1,502,971	$20.32M	0.0%	-17.8%	2.952%
5/16/2022	State Street Corp	171,195	$2.32M	0.0%	+65.2%	0.336%
5/16/2022	UBS Group AG	2,868	$39K	0.0%	-24.5%	0.006%
5/13/2022	Northern Trust Corp	86,252	$1.17M	0.0%	-7.6%	0.169%
5/13/2022	Charles Schwab Investment Management Inc.	73,803	$1M	0.0%	+3.5%	0.145%
5/12/2022	BlackRock Inc.	491,336	$6.67M	0.0%	-0.7%	0.965%
5/11/2022	Bank of New York Mellon Corp	24,242	$0.33M	0.0%	+38.1%	0.048%
5/11/2022	JPMorgan Chase & Co.	7,593	$0.10M	0.0%	-88.0%	0.015%
5/5/2022	New York State Common Retirement Fund	5,375	$73K	0.0%	N/A	0.011%
2/19/2022	Woodline Partners LP	120,000	$2.38M	0.0%	N/A	0.239%
2/14/2022	Citadel Advisors LLC	3,891,028	$74.74M	0.0%	N/A	7.736%
2/14/2022	venBio Partners LLC	5,011,536	$99.53M	17.9%	N/A	9.964%
2/14/2022	Third Point LLC	4,312,834	$83.08M	0.6%	N/A	8.575%
2/8/2022	Northern Trust Corp	93,365	$1.85M	0.0%	N/A	0.186%
2/7/2022	American Century Companies Inc.	392,750	$7.80M	0.0%	N/A	0.781%
1/26/2022	Tokio Marine Asset Management Co. Ltd.	12,400	$0.25M	0.0%	N/A	0.025%

Data available starting January 2016

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases. Its lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease. It is also developing VTX002, a sphingosine 1 phosphate receptor modulator that is in Phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 inflammasome inhibitor to treat patients with cryopyrin-associated periodic syndrome. In addition, the company is developing VTX3232, a CNS-penetrant NLRP3 inhibitor. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in Encinitas, California.

Today's Range

Now: $42.56

$41.84

$43.95

50 Day Range

MA: $33.42

$26.02

$43.95

52 Week Range

Now: $42.56

$9.50

$44.98

Volume

636,150 shs

Average Volume

672,826 shs

Market Capitalization

$2.41 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Ventyx Biosciences?: Ventyx Biosciences' top insider investors include:
Somu Subramaniam (Director)
Nsv Partners Iii Lp (Major Shareholder)
Raju Mohan (CEO)
Christopher W Krueger (Insider)
John Nuss (Insider)
Martin Auster (CFO)
Global Strategic Fund I Venbio (Major Shareholder)
William Richard White (Director)
Learn More about top insider investors at Ventyx Biosciences.
Who are the major institutional investors of Ventyx Biosciences?: Ventyx Biosciences' top institutional investors include:
Moody Aldrich Partners LLC — 0.14%
TD Asset Management Inc — 0.05%
Birchview Capital LP — 0.04%
Carnegie Capital Asset Management LLC — 0.03%
New York State Common Retirement Fund — 0.03%
Connective Portfolio Management LLC — 0.03%
Learn More about top institutional investors of Ventyx Biosciences stock.
Which institutional investors are selling Ventyx Biosciences stock?: Within the last quarter, VTYX stock was sold by these institutional investors:
Birchview Capital LP
Janney Montgomery Scott LLC
New York State Common Retirement Fund
Within the last year, company insiders that have sold Ventyx Biosciences company stock include:
Somu Subramaniam (Director)
Nsv Partners Iii Lp (Major Shareholder)
Raju Mohan (CEO)
Christopher W Krueger (Insider)
John Nuss (Insider)
Martin Auster (CFO)
Global Strategic Fund I Venbio (Major Shareholder)
Learn More investors selling Ventyx Biosciences stock.
Which institutional investors are buying Ventyx Biosciences stock?: During the last quarter, VTYX stock was acquired by institutional investors including:
Moody Aldrich Partners LLC
Carnegie Capital Asset Management LLC
Connective Portfolio Management LLC
TD Asset Management Inc
ProShare Advisors LLC
Avestar Capital LLC
SG Americas Securities LLC
Zurcher Kantonalbank Zurich Cantonalbank